IT Risk Management. Agenda. Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot
|
|
- Bruce Jacobs
- 8 years ago
- Views:
Transcription
1 IT Risk Management ISACA Switzerland Chapter After Hours Seminar Mario Walter Agenda Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 2
2 Corporate Setup Clear focus on innovating healthcare Two strong pillars Roche: Since 2004 healthcare company focused on pharmaceuticals and diagnostics Roche Diagnostics: A global leader in diagnostics Roche Pharmaceuticals: A global leader in biotechnology and key therapeutic areas 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 3 Basic facts Founded 1896 in Basel, Switzerland Employing around people Currently active in 150 countries on all continents 2005 sales (continuing businesses): 35.5 billion Swiss Francs Core businesses: Pharmaceuticals and Diagnostics Number 1 in the global diagnostics market (in vitro), the leading supplier of medicines for cancer & transplantation and a market leader in virology 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 4
3 Corporate Setup Roche Group Sales % local 20 % CHF in CHF m 25 % 26 % 4% 5 % ISACA After Hours Seminar IT Risk Management Mario Walter Seite 5 Roche strategy Innovation across the entire healthcare-spectrum Our capabilities in diagnostics and pharmaceuticals enable us to innovate across the entire healthcare spectrum, from identifying disease susceptibilities and disease screening in populations at risk to prevention, diagnosis, therapy and treatment monitoring. Predisposition Early detection Prevention Diagnosis Therapy Monitoring 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 6
4 Diagnostics Division Diagnostics market Market share 1 Sales growth 2 Roche Diagnostics Abbott J & J Bayer* Beckman C.* Dade Behring * DIA Market ** 1 Source: company reports, Boston Biomedical Consultants, Roche analysis 2 in local currencies; excludes Life Science research market * Based on nine months sales 2004 **IVD 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 7 Diagnostics Division Broadest product portfolio in the industry Life science research Diagnostics market Research Professionals Consumers research academia pharma biotech university hospital commercial lab hospital clinic GP patient Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 8
5 Diagnostics broadest portfolio Molecular Biochemicals Molecular Systems Clinical Chemistry Immunology Haematology Coagulation Blood Glucose Testing Urinanalysis Point of Care Blood gas/ electrolytes LightCycler, MagNA Pure LC COBAS AMPLICOR, AmpliScreen, AmpliPrep, TaqMan Roche/Hitachi and COBAS INTEGRA lines Elecsys and E170 (MODULAR ANALYTICS SWA) Sysmex systems STA-R, STA Compact, STA-R Evolution Products of the Accu-Chek family Miditron, Combur product line, Urisys CoaguChek, Cardiac Reader, Reflotron OMNI C/S COBAS, INTEGRA, ELECSYS, MIDITRON, MODULAR and URISYS are trademarks of Roche. STA and STA Compact are trademarks of Diagnostica STAGO S.A ISACA After Hours Seminar IT Risk Management Mario Walter Seite 9 Diagnostics Division Regional headquarters and R&D centers Indianapolis Pleasanton/ Alameda Rotkreuz Basel Burgdorf Mannheim Penzberg Graz Tokyo Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care Branchburg Barcelona Singapore Regional headquarters 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 10
6 Agenda Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 11 OSI Modell 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 12
7 The layers above 7 Layer 10 Regulations Layer 9 Finance Layer 8 Politics 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 13 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 14
8 E Frequent ~ 1 per day D Probable ~ every 10 days C Occasional ~ 3 times a year B Remote ~ once in 3 years A Improbable ~ once in 30 years Minor 2 Moderate 3 Considerable 4 Critical 5 Catastrophic How to tackle risks Strategic approach Probability 1 Severity Risk Operational approach Correlation 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 15 Strategic approach - The Project Global IT Security launched a project to: develop a comprehensive overview of all potential relevant IT risk scenarios throughout Roche Diagnostics systematically collect and assess the top major risk scenarios related to IT security present all collected information on IT risk scenarios in one single picture, i.e. the IT Risk Landscape as a sound basis for decision making define a top-down approach for improving IT security based on the high level IT Risk Landscape enable an optimal balance between accepting/mitigating risks and prioritization, resource allocation, timing, impact 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 16
9 Method A team of internal and external IT security experts systematically collected, described and evaluated Roche Diagnostics specific IT risk scenarios Elaborated the risk ratings (i.e. frequency and severity), based on professional judgment mapped the risk scenarios to operational risk management standards, e.g. COSO chose not extreme but realistic scenarios that could happen here and now organized a security-internal quality assurance with the DISN, the Diagnostics Information Security Network, team members developed a process for periodic update/maintenance of the IT Risk Landscape 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 17 The IT Risk Landscape Probability E Frequent ~ 1 per day D Probable ~ every 10 days C Occasional ~ 3 times a year b B Remote ~ once in 3 years a A Improbable ~ once in 30 years Minor 2 Moderate 3 Considerable 4 Critical 5 Catastrophic Severity 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 18
10 Security Operations Competency Center (SOCC) Overall Strategy: Integrated View supports risk management Impact Analysis. Threat Profile. Reduction falsepositives IDS Detection VM Correlation Log Files Prevention 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 19 Current Supported Services Detection and Prevention (Network) Global Pharmaceuticals Global Diagnostics 1 FTE 1 FTE Roche Global Security Operations and Competency Center Personal Firewall (Desktop) Global Diagnostics 1 FTE Vulnerability Management Global Pharmaceuticals Global Diagnostics 1 FTE 1 FTE 16 Hours Manned Coverage 7x24 on-call coverage 365 Days Per Year 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 20
11 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 21 A Single Integrated Solution Monitoring, Visualization, and Reporting Real-time Analysis, Correlation, and Workflow Event Collectors Firewalls Firewalls Detection Applications Firewalls Firewalls Systems Detection Applications Detection Applications Firewalls Systems Detection Systems Hosts Applications Applications Systems Applications Applications Detection Anti Systems Detection Detection Detection Virus Anti Systems Detection Systems Detection Detection Systems Detection Systems Detection Network Systems Systems Databases Virus Systems Equipment Systems Sign-On Sign-On Directory Services 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 22
12 A roadmap Provide senior management with traffic lights Complexity / Integration Create dashboards for your management Define a scoring system Time 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 23 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 24
13 5 body armour points Start small Convince / seduce your senior management Get a strong relationship with your operational people Be aware that people fear the new Be supportive, i.e. help projects achieve their goals 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 25 Questions 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 26
Accu-Chek Inform II system. Professional glucose testing for the wireless age
Accu-Chek Inform II system Professional glucose testing for the wireless age The Accu-Chek Inform II system Real time control The Accu-Chek Inform II System overview Quality Advanced chemistry with multiple
More informationBettina Marcinkowski, Roche Diagnostics GmbH
Roche an attractive employer Academic Recruiting, Career Services & Employer Branding Munich, February 27, 2012 Bettina Marcinkowski, Roche Diagnostics GmbH To share with you Passionate about recruiting
More informationConnecting solutions of excellence
MODULAR PRE-ANALYTICS EVO analyzer Connecting solutions of excellence COBAS, COBAS C, COBAS E, COBAS P, LIFE NEEDS ANSWERS, MODULAR ANALYTICS EVO, MODULAR PRE-ANALYTICS EVO, MODULAR, ELECSYS and COBAS
More informationNine-month sales show continued double-digit growth significantly above the market average
Investor Update Basel, 14 October 2004 Nine-month sales show continued double-digit growth significantly above the market average Roche Group Sales in core businesses up by 14%* to 21.9 billion Swiss francs
More informationRoche Support Network. Dependable technical, clinical and IT support delivered by experts who know your business
Roche Support Network Dependable technical, clinical and IT support delivered by experts who know your business Support you feel, but don t always see Solutions to optimize every aspect of your laboratory
More informationProactive recruitment and sourcing at Roche April 2014. Wiebke Bräuer
Proactive recruitment and sourcing at Roche April 2014 Wiebke Bräuer Basic facts at a glance Founded 1896 in Basel, Switzerland Founding families still hold majority stake Employing 85,000 people Currently
More informationRoche Diagnostics Driving Personalized Healthcare
r his presentation contains certain forward-looking statements. hese forward-looking statements may be identified by words such as believes, expects, anticipates, projects, intends, should, seeks, estimates,
More informationMedia Release. Basel, 11 June 2009. RA patients with enhanced response identified
Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients
More informationThe Roche HR Experience Map. Christine Renz Head of Attraction, Sourcing & Hiring Roche Basel
The Roche HR Experience Map Christine Renz Head of Attraction, Sourcing & Hiring Roche Basel Roche at a glance Founded 1896 in Basel, Switzerland Founding families still hold majority stake Employing 85,000
More informationDiagnostics Division. Roland Diggelmann COO Roche Diagnostics. Picture
Diagnostics Division Roland Diggelmann COO Roche Diagnostics Picture HY 2013: Roche Group highlights HY 2013 performance Strong Pharma performance, driven by US; solid growth for Diagnostics 12% core EPS
More informationBackground Information
Background Information r One About NAT Testing NAT testing has been widely embraced by laboratories throughout the world as a means to identify CT cases because of its high degree of accuracy and reliability
More informationWAN security threat landscape and best mitigation practices. Rex Stover Vice President, Americas, Enterprise & ICP Sales
WAN security threat landscape and best mitigation practices. Rex Stover Vice President, Americas, Enterprise & ICP Sales The Cost of Cybercrime Sony $171m PlayStation 3 data breach (April 2011) $3 trillion
More informationWorldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019. February 2015
Worldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019 February 2015 INTELAB CORPORATION MARKET AND TECHNOLOGY REPORTS Report 530 Copyright 2015 Worldwide Markets and Emerging
More informationProducts and Solutions 2015 Roche Diagnostics
Products and Solutions 2015 Roche Diagnostics I i I a I i healthy At Roche Diagnostics, we re giving you the answers today for a healthier tomorrow. We give you The Power of Knowing Diseases raise many
More informationF. Hoffmann-La Roche AG chooses enteo NetInstall to manage software packaging and distribution
enteo I success story GLOBAL DISTRIBUTION F. Hoffmann-La Roche AG chooses enteo NetInstall to manage software packaging and distribution Global structures require global management. Central administration
More information91,747 employees in over 100 countries
Roche in Brief 2015 Roche Who we are Who we are Roche Who we are 91,747 employees in over 100 countries CHF 48.1 bn in Group sales in 2015 # 1 in biotech, oncology, in vitro diagnostics and hospital market
More informationManufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH
Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH VWR enables the advancement of science by providing high-quality chemicals and services, customized to your
More informationRoche in Switzerland Innovation is our home
Roche in Switzerland Innovation is our home Roche s sites in Switzerland in context Roche was founded by Fritz Hoffmann-La Roche on 1 October 1896. He was one of the first people to recognise that major
More informationAbbott Diagnostics. Durable Growth Business
Abbott Diagnostics Durable Growth Business Forward-Looking Statement Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation Reform Act
More informationWelcome to Penzberg. One of Europe s largest biotech facilities
Welcome to Penzbeg One of Euope s lagest biotech facilities The Roche Goup s lagest biotech facility The Penzbeg site Pofile Role Diagnostics Phamaceuticals Futue Whee it all began The Penzbeg site in
More informationCommitted to innovation and growth
Committed to innovation and growth Alan Hippe, CFO Roche Group London, September 2012 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by
More informationRoche Turkey Corporate Responsibility Report 2013. Improving lives - now and in the future
Roche Turkey Corporate Responsibility Report 2013 Improving lives - now and in the future Highlights of 2013 DJSI industry leader for the fifth time in a row High levels maintained in ethics and compliance
More informationInvestor Update. Roche posts very strong interim results. Basel, 20 July 2005
Investor Update Basel, 20 July 2005 Roche posts very strong interim results Roche Group Group sales up 17%. Pharmaceutical sales grow three times faster than the global market Operating profit rises 30%,
More informationSMF Awareness Seminar 2014
SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD
More informationMSc in Toxicology. Master Degree Programme
Master Degree Programme MSc in Toxicology Department of Pharmaceutical Sciences, University of Basel Swiss Centre for Applied Human Toxicology (SCAHT) Master of Science in Toxicology University of Basel
More informationEiCon G.m.b.H. Diagnostic Healthcare Consulting. Amtsgericht Lörrach : HRB-Nr.3002. E-Mail : info@eiconnet.de. Home page: http://www.eiconnet.
EiCon G.m.b.H. Diagnostic Healthcare Consulting Amtsgericht Lörrach : HRB-Nr.3002 Unterbaselweg 55 D -79576 Weil am Rhein Germany Phone : (49) - 7621-798373 Fax : (49) - 7621-798374 Hauptstrasse 160 D-79576
More informationGlobal Monoclonal Antibodies Pipeline Insight 2015
Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who
More informationAutomating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
More informationInnovative people need room to breathe
92/93 Arthur D. Little How important is the protection of intellectual property to sustaining innovation in your business? Schwan Without patents there would be no innovation in our industry. Patents are
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationCommitted to innovation and growth
Committed to innovation and growth Roland Diggelmann, COO Roche Diagnostics Bad Ragaz, 16 Jan 2015 Business model & strategy Q3 2014 overview Major products, launches and newsflow Building a leading sequencing
More informationCentro de Salud México España Centro de Salud San Francisco Culhuacán Mexico City, Mexico
Centro de Salud México España Centro de Salud San Francisco Culhuacán Mexico City, Mexico Mexico City is one of the largest cities in the world and home to over 21 million people. The population is culturally
More informationEffective Methods to Detect Current Security Threats
terreactive AG. Swiss Cyber Storm 2015. Effective Methods to Detect Current Security Threats Taking your IT security to the next level, you have to consider a paradigm shift. In the past companies mostly
More informationBEIPH Final Report. QCMD 2010 Hepatitis B Virus DNA (HBVDNA10A) EQA Programme. William G MacKay on behalf of QCMD and its Scientific Council July 2010
QUALITY CONTROL for MOLECULAR DIAGNOSTICS The Altum Building, Todd Campus, West of Scotland Science Park, Glasgow, G20 0XA Scotland Tel: +44 (0) 141 945 6474 Fax: +44 (0) 141 945 5795 www.qcmd.org info@qcmd.org
More informationClinical Chemistry Analyzers
Brochure More information from http://www.researchandmarkets.com/reports/562864/ Clinical Chemistry Analyzers Description: Clinical chemistry analysis is one of the most important areas within clinical
More informationAdvaMedDx.org 4 EDMA and its Market Intelligence Activities EDMA Statistics Evolution Up to the late 80 s no harmonized IVD market statistics National trade associations in Europe established their own
More informationSamsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT
Samsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT Alexander Belenky, PhD Director -Product Development Samsung - Nexus-Dx Edward Brennan, PhD
More informationLOG AND EVENT MANAGEMENT FOR SECURITY AND COMPLIANCE
PRODUCT BRIEF LOG AND EVENT MANAGEMENT FOR SECURITY AND COMPLIANCE The Tripwire VIA platform delivers system state intelligence, a continuous approach to security that provides leading indicators of breach
More informationCyber Security: Software Security and Hard Drive Encryption
Links in this document have been set for a desktop computer with the resolution set to 1920 x 1080 pixels. Cyber Security: Software Security and Hard Drive Encryption 301-1497, Rev A September 2012 Copyright
More informationCASE STUDY. NHS Board. Contact. Email. Title. Category. Background/ context. NHS Tayside
NHS Board Contact Email NHS Tayside Dr Bill Bartlett (Consultant Clinical Scientist), Tejinder Chima (Clinical Services Manager) bill.bartlett@nhs.net, tchima@nhs.net Title Category Background/ context
More informationInform II. Quick Reference Guide. for Healthcare Professionals BLOOD GLUCOSE MONITORING SYSTEM
Inform II BLOOD GLUCOSE MONITORING SYSTEM Quick Reference Guide for Healthcare Professionals 2 Table of Contents Important... 4 General Information... 6 ACCU-CHEK Inform II Meter...10 How to Perform Patient
More informationAn important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and
An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and CoaguChek systems Cardiovascular disease: the #1 killer in
More informationAnnual General Meeting of Roche Holding Ltd 2 March 2010
r Annual General Meeting of Roche Holding Ltd 2 March 2010 Address by Severin Schwan CEO of the Roche Group (Check against delivery.) Address by Severin Schwan Page 2 of 14 Ladies and Gentlemen, Fellow
More informationAccenture Intelligent Security for the Digital Enterprise. Archer s important role in solving today's pressing security challenges
Accenture Intelligent Security for the Digital Enterprise Archer s important role in solving today's pressing security challenges The opportunity to improve cyber security has never been greater 229 2,287
More informationEvalution the multiplexed analysis of biomarkers made fast and simple by MyCartis
Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis We are MyCartis Let s make healthcare personal The big revolution in healthcare today is that we are finally realizing
More informationBusiness Challenges Over the Past 40 Years
Special Feature 2: Business Challenges Over the Past 40 Years Sysmex started operating in 1968 to sell hematology analyzers manufactured by TOA Electric Co., Ltd. (now TOA Corporation). Sysmex has faced
More informationehr Sharable Data Vicky Fung Senior Health Informatician ehr Information Standards Office
ehr Sharable Data Vicky Fung Senior Health Informatician ehr Information Standards Office ehr - Vision DH HA epr Private Private Hospit als Hospitals EHR Repository Access Portal CMS onramp PPP Clinics
More informationIntelligent laboratory management Delivered by cobas IT middleware
For technical specifications and additional information please see the enclosed datasheets. Intelligent laboratory management Delivered by cobas IT middleware To arrange a meeting or demonstration to learn
More informationA MULTIFACETED CYBERSECURITY APPROACH TO SAFEGUARD YOUR OPERATIONS
A MULTIFACETED CYBERSECURITY APPROACH TO SAFEGUARD YOUR OPERATIONS CYBER ATTACKS INFILTRATE CRITICAL INFRASTRUCTURE SECTORS Government and enterprise critical infrastructure sectors such as energy, communications
More informationThe Academy of Clinical Science and Laboratory Medicine Pathways to Fellowship
The Academy of Clinical Science and Laboratory Medicine Revision 1 February 2015. Contents: 1 Introduction... 2 2 Constitution... 2 3 Qualification... 2 3.1 Accredited Masters Programmes... 3 3.2 Approved
More informationEffective Methods to Detect Current Security Threats
terreactive AG. Swiss Cyber Storm 2015. Effective Methods to Detect Current Security Threats Enrico Petrov Director Managed Security Services terreactive October 21 st, 2015 terreactive Background. About
More informationHospital Blood Glucose Testing Innovation with wireless connectivity
Hospital Blood Glucose Testing Innovation with wireless connectivity Content Savings thanks to wireless connectivity Instant information availability enabling process optimisation and cost savings. General
More informationExpert workflow management cobas p 312 pre-analytical system The new dimension of laboratory automation
Expert workflow management cobas p 312 pre-analytical system The new dimension of laboratory automation Expert workflow management Concept Professional management of laboratory processes in terms of workflow
More informationWireless Technologies in Medical Devices: Market - IP Landscape
1.0 Background This document serves as a sample Market-IP analysis report. It proposes to provide the reader with information relating to the products in the market and in general to patent landscape analysis.
More informationFDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma
Media Release Basel, 31 January 2011 FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma Approval provides option that improves the length of time people with incurable
More informationPresented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
More informationAccu-Chek Connect Online diabetes management system. Setup Guide for Healthcare Providers
Accu-Chek Connect Online diabetes management system Setup Guide for Healthcare Providers Setup Accu-Chek Connect Online diabetes management system Welcome to the Accu-Chek Connect Online diabetes management
More informationRoche Diagnostics Business Insight
Published by F. Hoffmann-La Roche Ltd Group Communications 4070 Basel, Switzerland Roche Diagnostics Business Insight 2014 All trademarks mentioned enjoy legal protection. www.roche.com 7 000 969 [Open
More informationLOG MANAGEMENT AND SIEM FOR SECURITY AND COMPLIANCE
PRODUCT BRIEF LOG MANAGEMENT AND SIEM FOR SECURITY AND COMPLIANCE As part of the Tripwire VIA platform, Tripwire Log Center offers out-of-the-box integration with Tripwire Enterprise to offer visibility
More informationWe Innovate Healthcare
Part 2 Roche Annual Report 2007 Finance Report We Innovate Healthcare We Innovate Healthcare As a research-intensive healthcare company, Roche discovers, develops and provides innovative diagnostic and
More informationHealth Data Cooperatives Citizen-Controlled Health Data Repositories as a Basis for Big Data Analytics in Health
Health Data Cooperatives Citizen-Controlled Health Data Repositories as a Basis for Big Data Analytics in Health ehealth2014 May 12-14 2014, Athens Prof. Ernst Hafen Behavior Health Drugs Therapy Genome
More informationMetrics that Matter Security Risk Analytics
Metrics that Matter Security Risk Analytics Rich Skinner, CISSP Director Security Risk Analytics & Big Data Brinqa rskinner@brinqa.com April 1 st, 2014. Agenda Challenges in Enterprise Security, Risk
More informationST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare
ST. VINCENT'S MEDICAL CENTER St. Vincent's Healthcare Medical Technology St. Vincent s Schools of Medical Science Throughout Northeast Florida and Southern Georgia, St. Vincent s HealthCare is well known
More informationDiagnostics: Growth through innovation and Personalised Healthcare. Daniel O Day, COO Roche Diagnostics
Diagnostics: Growth through innovation and Personalised Healthcare Daniel O Day, COO Roche Diagnostics Roche Diagnostics portfolio overview Industry leading businesses covering the entire IVD spectrum
More informationRoche Interim results 2006. Roche Interim Results 2006 July 20, 2006 1
r Roche Interim results 2006 London, July 20, 2006 July 20, 2006 1 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as believes,
More informationcobas connection modules (CCM) Sample flow solutions for high-throughput laboratories
cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories Expert workflow management The fast track to sample flow efficiency Professional management of laboratory processes
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationDiagnostics In 2009 sales again
Diagnostics In 2009 sales again grew well ahead of the market, with strong uptake of new products contributing to market share gains in key segments such as immunoassays and tissue diagnostics. All business
More informationcobas connection modules (CCM) Sample flow solutions for high-throughput laboratories
cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories Expert workflow management The fast track to sample flow efficiency Professional management of laboratory processes
More informationIBM QRadar Security Intelligence April 2013
IBM QRadar Security Intelligence April 2013 1 2012 IBM Corporation Today s Challenges 2 Organizations Need an Intelligent View into Their Security Posture 3 What is Security Intelligence? Security Intelligence
More informationSelling into Life Science Research 2020 The ecommerce shift
www.pwc.com Selling into Life Science Research 2020 The ecommerce shift Dr. Nikolas Beutin Dr. David Pumberger Agenda Page 1 Today s Life Science Research Market 1 2 The ecommerce shift 5 3 Way forward
More informationHealthcare Solid performance, strong perspectives Siemens Capital Market Day Berlin, December 9, 2014
Hermann Requardt Member of the Managing Board & Healthcare CEO Healthcare Solid performance, strong perspectives Siemens Capital Market Day Notes and forward-looking statements This document contains statements
More informationAternity Mobile Wrapper. Overview and Use Cases
Aternity Mobile Wrapper Overview and Use Cases Aternity Mobile Wrapper enables enterprises to instrument apps for diagnostics and user interactions no developer required! Assuring mobile workforce productivity
More informationMYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME
FOR IMMEDIATE RELEASE MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME - $185 Million Collaboration to Determine All Human Protein Interactions And Decipher Biochemical Pathways
More informationOur values help us to create added value in a sustainable way. Sustainability includes fostering and retaining our most talented employees
Our values help us to create added value in a sustainable way Sustainability includes fostering and retaining our most talented employees 32 Sustainability Report 2004 Creating value through sustainable
More informationImproving Health Outcomes and Reducing Costs with Video Conferencing Technology
Case Study Intel Intel Health & Life Sciences Improving Health Outcomes and Reducing Costs with Video Conferencing Technology The fundamental concept is to provide the patient with care where they are
More informationTRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3)
TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3) CAT NO. CQ3259 LOT NOS. 3190CK, 3191CK, 3192CK SIZE: 3 x 2ml EXPIRY: 2015-02 INTENDED USE This product is intended for in vitro diagnostic use in the quality
More informationValue Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector
Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and
More informationBiotech Opportunities for Start-Up Firms in Japan and Asia
Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma
More informationQRadar SIEM 6.3 Datasheet
QRadar SIEM 6.3 Datasheet Overview Q1 Labs flagship solution QRadar SIEM is unrivaled in its ability to provide an organization centralized IT security command and control. The unique capabilities of QRadar
More informationSpecial Feature: Growth Model of an Agile Company
Special Feature: Growth Model of an Agile Company 15 Sysmex s Global Strategy From the time of its establishment, Sysmex has followed a steady growth trajectory, and the Group now provides products and
More informationNetwork Performance Monitoring at Minimal Capex
Network Performance Monitoring at Minimal Capex Some Cisco IOS technologies you can use to create a high performance network Don Thomas Jacob Technical Marketing Engineer About ManageEngine Network Servers
More informationObtaining Enterprise Cybersituational
SESSION ID: SPO-R06A Obtaining Enterprise Cybersituational Awareness Eric J. Eifert Sr. Vice President Managed Security Services DarkMatter Agenda My Background Key components of the Cyber Situational
More informationBIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
More informationPOINT OF CARE DIAGNOSTIC TESTING AND SECTOR TRENDS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications November 2011 Volume: TMRPOCST11-1101 POINT OF CARE DIAGNOSTIC TESTING AND SECTOR TRENDS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers
More information40 Years of Color Innovation
Datacolor 40 Years of Color Innovation Swiss Equity Conference 2010 ALBERT BUSCH & MARK LEUCHTMANN SEPTEMBER 15, 2010 0 Safe Harbor Statement This document has been prepared by the Company solely for the
More informationcobas 8100 automated workflow series 3-D intelligence in lab automation
cobas 8100 automated workflow series 3-D intelligence in lab automation Personalized Lab Automation Maximizing Testing Efficiency and Medical Value At Roche, laboratory automated solutions deliver the
More informationThe Texas Biotechnology Industry
The Texas Biotechnology Industry 2014 Fortune 1000 company NBTY opens state-of-the-art vitamin manufacturing plant in San Antonio See Page 15 Allergan installs new production line at Waco pharmaceutical
More informationDiabetes & blindness. due to DME BLINDNESS IN EUROPE
Diabetes & blindness due to DME BLINDNESS IN EUROPE Blindness is a life-changing disability which puts a heavy strain on the daily lives of sufferers, their families, and society at large. Today, 284 million
More informationLast Name First Name: Term of graduation Departmental Approval
Biochemistry - Pre-Health Science Track BS Degree Completion Checklist Last Name First Name: _ GT ID #_ Catalog Year Date Term of graduation Departmental Approval _ Total Semester Credit Hours Required
More informationMedical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives
Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate
More informationTechnology and Expertise Add Operational Value to Medical Device Trials
Technology and Expertise Add Operational Value to Medical Device Trials Copyright 2015 Medidata Solutions. Medidata Solutions and other trademarks reserved in the US and globally. Medidata and other marks
More informationAvg cost of a complex trial $100mn. Avg cost per patient for a Phase III Study
1 Industry Perspective Over the last several years, clinical research costs have sky rocketed while new drug approvals are at multi-year lows. Studies have become global in nature and more complex to manage
More informationUniversity Hospital Ulm Ulm, Germany. Prof. Dr. Dr. Dr. h.c. Max G. Bachem, Director Kerstin Stöhrer, Technical Supervisor
University Hospital Ulm Ulm, Germany Prof. Dr. Dr. Dr. h.c. Max G. Bachem, Director Kerstin Stöhrer, Technical Supervisor The University Hospital Ulm was founded in 1982. In 30 years it has built an enviable
More informationCombating Fraud, Waste, and Abuse in Healthcare
Combating Fraud, Waste, and Abuse in Healthcare ABSTRACT This paper discusses how real time analytics and event intelligence technologies can be used to analyze, detect, and prevent fraud, waste, and abuse
More informationFive things your company needs to do to prepare for the influence of Accountable Care Organizations
Five things your company needs to do to prepare for the influence of Accountable Care Organizations An extract from Pricing & Market Access Outlook 2013 Edition Five things your company needs to do to
More informationEPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing
More informationIntroduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure
Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National
More informationEnabling the Health Continuum with Informatics. Jeroen Tas Healthcare Informatics.Solutions.Services
Enabling the Health Continuum with Informatics Jeroen Tas Healthcare Informatics.Solutions.Services The changing global healthcare landscape requires a fundamentally different informatics approach Enabling
More informationInformation Technology Engineers Examination. Network Specialist Examination. (Level 4) Syllabus. Details of Knowledge and Skills Required for
Information Technology Engineers Examination Network Specialist Examination (Level 4) Syllabus Details of Knowledge and Skills Required for the Information Technology Engineers Examination Version 2.0
More information